0001593968-19-001743.txt : 20190816
0001593968-19-001743.hdr.sgml : 20190816
20190816160650
ACCESSION NUMBER: 0001593968-19-001743
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190814
FILED AS OF DATE: 20190816
DATE AS OF CHANGE: 20190816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MICHEL GERARD J
CENTRAL INDEX KEY: 0001235644
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35280
FILM NUMBER: 191033512
MAIL ADDRESS:
STREET 1: 420 CHIPETA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vericel Corp
CENTRAL INDEX KEY: 0000887359
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943096597
STATE OF INCORPORATION: MI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 7349305555
MAIL ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC
DATE OF NAME CHANGE: 19960428
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2019-08-14
0000887359
Vericel Corp
VCEL
0001235644
MICHEL GERARD J
C/O VERICEL CORPORATION
64 SIDNEY STREET
CAMBRIDGE
MA
02139
false
true
false
false
CFO and VP, Corp. Development
Common Stock
2019-08-14
4
M
false
17000
3.02
A
140182
D
Common Stock
2019-08-14
4
S
false
17000
16.6204
D
123182
D
Stock Option (right to buy)
3.02
2019-08-14
4
M
false
17000
0
D
2025-01-05
Common Stock
17000
69769
D
The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2018.
These options, representing the right to purchase a total of 180,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted.
/s/ Dominick C. Colangelo, Attorney-in-Fact for Gerard Michel
2019-08-16